133 results on '"Laugesen E"'
Search Results
2. 24-h ambulatory pulse wave velocity and central blood pressure in type 2 diabetes
3. Latent autoimmune diabetes of the adult: current knowledge and uncertainty
4. Pulse pressure and systolic night–day ratio interact in prediction of macrovascular disease in patients with type 2 diabetes mellitus
5. Ambulatory pulse pressure, decreased nocturnal blood pressure reduction and progression of nephropathy in type 2 diabetic patients
6. Aortic stiffness, peripheral and central haemodynamics in patients with screen-detected type 2 diabetes: the ADDITION-Denmark study
7. Objective measurements of activity patterns in people with newly diagnosed Type 2 diabetes demonstrate a sedentary lifestyle
8. P9.3 Lower Subendocardial Viability Ratio in Diabetic Women—Contributing to the Abrogated Cardioprotective Effect of Female Gender in Diabetes?
9. Macrophage-derived microvesicles is associated with vulnerable plaques in the coronary arteries of patients with type 2 diabetes and non-diabetic controls
10. 2.5 Comparison of Non-Invasive and Invasive Measurements of Central Blood Pressure in Patients with Chronic Kidney Disease
11. Effect of 12 weeks continuous positive airway pressure on day and night arterial stiffness in patients with type 2 diabetes and obstructive sleep apnoea, a randomised trial
12. Differential vascular effects of aspirin in people with Type 2 diabetes without cardiovascular disease and matched controls without diabetes
13. Inaccurate Cuff-Blood Pressure Misses Potentially Preventable Cardiovascular Events and Increases Health Costs: a Markov Modelling Study from Real Patient Data
14. P5.23: A Medical Conference Dinner’s Impact on Central Blood Pressure and Vascular Age
15. Arterial stiffness in people with Type 2 diabetes and obstructive sleep apnoea
16. Plasma levels of MASP-1, MASP-3 and MAp44 in patients with type 2 diabetes: influence of glycaemic control, body composition and polymorphisms in the MASP1 gene
17. Invasive Validation of Arteriograph Estimates of Central Blood Pressure in Patients With Type 2 Diabetes
18. Pulse pressure and systolic night–day ratio interact in prediction of macrovascular disease in patients with type 2 diabetes mellitus
19. Increased Ambulatory Arterial Stiffness Index and Pulse Pressure in Microalbuminuric Patients With Type 1 Diabetes
20. "Under Pressure": But Which Modality?
21. Lower subendocardial viability ratio in diabetic women–Contributing to the abrogated cardioprotective effect of female gender in diabetes?
22. Comparison of non-invasive and invasive measurements of central blood pressure in patients with chronic kidney disease
23. A medical conference dinner's impact on central blood pressure and vascular age
24. Assessment of postprandial glucose excursions throughout the day in newly diagnosed type 2 diabetes.
25. Ambulatory arterial stiffness index: a composite index reflecting arterial stiffness, blood pressure variability and patients' diurnal cycle.
26. Effects of semaglutide, empagliflozin and their combination on renal diffusion-weighted MRI and total kidney volume in patients with type 2 diabetes: a post hoc analysis from a 32 week randomised trial.
27. From Stability to Variability: Classification of Healthy Individuals, Prediabetes, and Type 2 Diabetes Using Glycemic Variability Indices from Continuous Glucose Monitoring Data.
28. One size does not fit all: universal cuff overestimates oscillometric blood pressure in persons with large arm circumference.
29. Correction: Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.
30. Obstructive sleep apnea, coronary calcification and arterial stiffness in patients with diabetic kidney disease.
31. Separate and combined effects of empagliflozin and semaglutide on vascular function: A 32-week randomized trial.
32. Feasibility of Arteriograph 24 for evaluation of 24-hour pulse wave velocity and central blood pressure in patients with type 2 diabetes and non-diabetic controls.
33. Metabolic Communication by SGLT2 Inhibition.
34. The effects of semaglutide, empagliflozin and their combination on the kidney sodium signal from magnetic resonance imaging: A prespecified, secondary analysis from a randomized, clinical trial.
35. Invasively Measured Aortic Systolic Blood Pressure and Office Systolic Blood Pressure in Cardiovascular Risk Assessment in CKD.
36. Effects of semaglutide and empagliflozin on oxygenation, vascular autoregulation, and central thickness of the retina in people with type 2 diabetes: A prespecified secondary analysis of a randomised clinical trial.
37. Separate and combined effects of semaglutide and empagliflozin on kidney oxygenation and perfusion in people with type 2 diabetes: a randomised trial.
38. Evaluation of renal oxygenation by BOLD-MRI in high-risk patients with type 2 diabetes and matched controls.
39. Sex Differences in Blood Pressure and Potential Implications for Cardiovascular Risk Management.
40. Distinct and opposite effects of leukemogenic Idh and Tet2 mutations in hematopoietic stem and progenitor cells.
41. Cardiovascular autonomic reflex tests using a handheld device in the diagnosis of cardiovascular autonomic neuropathy in patients with schizophrenia.
42. Long-term effects of intensive multifactorial treatment on aortic stiffness and central hemodynamics after 13 years with screen-detected type 2 diabetes: the ADDITION-Denmark trial.
43. Estimated Pulse Wave Velocity Is Associated With All-Cause Mortality During 8.5 Years Follow-up in Patients Undergoing Elective Coronary Angiography.
44. Glucose variability and low bone turnover in people with type 2 diabetes.
45. Changes in vascular function during breast cancer treatment.
46. Low physical activity is associated with impaired endothelial function in patients with type 2 diabetes and controls after 5 years of follow-up.
47. Characteristics of cardiovascular autonomic dysfunction and association with quality of life in patients with systemic lupus erythematosus.
48. Arterial stiffness and progression of cerebral white matter hyperintensities in patients with type 2 diabetes and matched controls: a 5-year cohort study.
49. Reply.
50. Invasive aortic pulse pressure is not superior to cuff pulse pressure in cardiovascular risk prediction.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.